Evidence map›Paper›PMID 28408792›Full record

ArticleMediators of inflammation2017

Thrombopoietin Receptor Agonist Mitigates Hematopoietic Radiation Syndrome and Improves Survival after Whole-Body Ionizing Irradiation Followed by Wound Trauma.

Juliann G Kiang, Min Zhai, Pei-Jun Liao, Connie Ho, Nikolai V Gorbunov, Thomas B Elliott

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Cell Therapies for Acute Radiation Syndrome.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Juliann G KiangRadiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.ORCID 0000-0002-3904-2350
Min ZhaiRadiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
Pei-Jun LiaoRadiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
Connie HoRadiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.ORCID 0000-0002-1056-6951
Nikolai V GorbunovRadiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.ORCID 0000-0001-6535-4553
Thomas B ElliottRadiation Combined Injury Program, Armed Forces Radiobiology Research Institute, Bethesda, MD 20889, USA.
Armed Forces Institute of Pathology · USBerkeley College · USUniformed Services University of the Health Sciences · US

Funding

NIAID NIH HHS Y01 AI005045
6 · The paper itself

Abstract

Ionizing radiation combined with trauma tissue injury (combined injury, CI) results in greater mortality and H-ARS than radiation alone (radiation injury, RI), which includes thrombocytopenia. The aim of this study was to determine whether increases in numbers of thrombocytes would improve survival and mitigate H-ARS after CI. We observed in mice that WBC and platelets remained very low in surviving RI animals that were given 9.5 Gy

Indexed as

AnimalsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBody WeightFemaleGamma RaysMiceRadiation InjuriesReceptors, ThrombopoietinWhole-Body IrradiationWound HealingWounds and InjuriesALXN4100Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedReceptors, Thrombopoietin

Identifiers

PMID28408792
PMCPMC5376937
OpenAlexW2601630984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.